Skip to main content

Advertisement

SpringerLink
Log in

Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors

  • Correspondence
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, et al. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors. Clin Transl Oncol. 2018. https://doi.org/10.1007/s12094-018-1983-4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Talcott JA. Decision rules in a guideline: allow the science to speak. J Clin Oncol. 2018;36:3174.

    Article  Google Scholar 

  3. Taplitz RA, Kennedy EB, Flowers CR. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update summary. J Oncol Pract. 2018;14(4):250–5.

    Article  PubMed  Google Scholar 

  4. Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, et al. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: The EPIPHANY Index. Br J Cancer. 2017;116:994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008;26:606–11.

    Article  PubMed  Google Scholar 

  6. Carmona-Bayonas A, Jiménez-Fonseca P, Echaburu JV, Antonio M, Font C, Biosca M, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015;33(5):465–71.

    Article  PubMed  Google Scholar 

  7. Koppaka D, Kuntegowdanahalli LC, Lokanath D, Babu KG, Jacob LA, Babu MCS, et al. 421O Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Ann Oncol. 2018;29:mdy444-001.

    Article  Google Scholar 

  8. Hae M. Validation of clinical index of stable febrile neutropenia (CISNE) model: can it guide emergency physicians to a reasonable decision on outpatient vs. hospitalization? 2018 MASCC/ISOO annual meeting. Supp Care Cancer. 2018;26(Supplement 2):39–364.

  9. Klastersky J, Paesmans M. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Supp Care Cancer. 2013;21(5):1487–95.

    Article  Google Scholar 

  10. Carmona-Bayonas A, Jiménez-Fonseca P, Echaburu JV, Cánovas MS, de la Peña FA. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score. Clin Transl Oncol. 2017;19:1084–90.

    Article  CAS  PubMed  Google Scholar 

  11. Carmona-Bayonas A, Gómez J, González-Billalabeitia E, Canteras M, Navarrete A, Gonzálvez ML, et al. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br J Cancer. 2011;105:612–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fonseca PJ, Carmona-Bayonas A, García IM, Marcos R, Castañón E, Antonio M, et al. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia. Br J Cancer. 2016;114:1191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ahn S, Rice TW, Yeung SJ, Cooksley T. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents. Support Care Cancer. 2017;26(5):1465–70.

    PubMed  Google Scholar 

Download references

Acknowledgements

Priscilla Chase Duran for editing and improving this manuscript.

Funding

None.

Author information

Authors and Affiliations

  1. Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain

    A. Carmona-Bayonas

  2. Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

    P. Jiménez-Fonseca

Authors
  1. A. Carmona-Bayonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Jiménez-Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Carmona-Bayonas.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, no informed consent is required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carmona-Bayonas, A., Jiménez-Fonseca, P. Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors. Clin Transl Oncol 21, 1112–1114 (2019). https://doi.org/10.1007/s12094-018-02020-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-018-02020-8

Search

Navigation